Microvascular Endothelial Dysfunction in Patients with Obesity
- 101 Downloads
Purpose of Review
To examine the state of the art on the pathogenesis of endothelial dysfunction in the microcirculation of patients with obesity, focusing on the complex relationship between the consolidated and the novel mechanisms involved in this alteration.
Human obesity is associated with vascular endothelial dysfunction, caused by a reduced nitric oxide availability secondary to an enhanced oxidative stress production. Pro-inflammatory cytokine generation, secreted by perivascular adipose tissue, is a major mechanism whereby obesity is associated with a reduced vascular NO availability. Vasculature also represents a source of low-grade inflammation and oxidative stress which contribute to endothelial dysfunction in obese patients. Recently, a direct influence of arginase on endothelial function by reducing nitric oxide availability was demonstrated in small vessels from patients with severe obesity. This effect is modulated by ageing and related to the high levels of vascular oxidative stress.
Oxidative stress, inflammation, and enzymatic pathways are important players in the pathophysiology of obesity-related vascular disease. The identification of new therapeutic approaches able to interfere with these mechanisms will result in more effective prevention of the cardiovascular complications associated with obesity.
KeywordsCytokines Endothelium Microcirculation Obesity Oxidative stress
Compliance with Ethical Standards
Conflict of Interest
The authors declare no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•• Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27 This systematic review provides one of the most comprehensive assessments of the trends and disease burden of high body mass index to date, demonstrating that excess body weight is a major risk factor for mortality and morbidity, accounting for 4.0 million deaths and 120 million disability adjusted life years worldwide. CrossRefGoogle Scholar
- 7.Marinova GV, Loyaga-Rendon RY, Obayashi S, Ishibashi T, Kubota T, Imamura M, et al. Possible involvement of altered arginase activity, arginase type I and type II expressions, and nitric oxide production in occurrence of intimal hyperplasia in premenopausal human uterine arteries. J Pharmacol Sci. 2008;106:385–93.CrossRefPubMedGoogle Scholar
- 16.•• van der Heijden DJ, van Leeuwen MAH, Janssens GN, Lenzen MJ, van de Ven PM, Eringa EC, et al. Body mass index is associated with microvascular endothelial dysfunction in patients with treated metabolic risk factors and suspected coronary artery disease. J Am Heart Assoc. 2017;6:e006082 This study shows that high body mass index is associated with endothelial dysfunction in peripheral microcirculation of patients with suspected coronary artery disease, even in individuals with treated metabolic risk factors. PubMedPubMedCentralGoogle Scholar
- 33.•• Ghanim H, Monte S, Caruana J, Green K, Abuaysheh S, Dandona P. Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery. Diabetes, Obes Metab. 2018;20:2029–33 This study provides a demonstration that a reduction in body weight secondary to bariatric surgery leads to a reduction in inflammation and insulin resistance nd associated with a fall in the circulating levels of molecules with a negative effect on vascular homeostasis. CrossRefGoogle Scholar
- 37.•• Bhatta A, Yao L, Xu Z, Toque HA, Chen J, Atawia RT, et al. Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1. Cardiovasc Res. 2017;113:1664–76 This experimental study demonstrates for the first time that high fat diet impairs endothelial-dependent vasorelaxation, arterial fibrosis, and stiffening by a mechanism involving the expression of arginase 1 in vascular endothelial cells. CrossRefPubMedPubMedCentralGoogle Scholar
- 40.•• Masi S, Colucci R, Duranti E, Nannipieri M, Anselmino M, Ippolito C, et al. Aging modulates the influence of arginase on endothelial dysfunction in obesity. Arterioscler Thromb Vasc Biol. 2018;38:2474–83 This study shows that in small human arteries, arginase contributes to endothelial dysfunction detected in obese subjects by reducing NO availability. The influence of arginase on microvascular endothelial function is attenuated by aging, as it is modulated by levels of vascular oxidative stress. CrossRefPubMedGoogle Scholar
- 41.•• El Assar M, Angulo J, Santos-Ruiz M, Ruiz de Adana JC, Pindado ML, Sanchez-Ferrer A, et al. Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. J Physiol. 2016;594:3045–60 This study conducted in humans and animals shows that an upregulation of arginase activity contributes to the endothelial dysfunction as a result of the presence of insulin resistance in individuals with morbid obesity. CrossRefPubMedPubMedCentralGoogle Scholar